American Journal of Clinical Oncology
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Adverse Events in Patients Receiving Platinum Analog-Based Chemotherapy
Cohort study of 200 peopleInterventions
- GLP-1 receptor agonists
- 5-ht3 receptor antagonists
- GLP-1 and incretin signalling
- Gastrointestinal adverse effects
- Hypothyroidism
- Humans
The paper
The University of Texas Health Science Center at Houston; The University of Texas MD Anderson Cancer Center
American Journal of Clinical Oncology, 10 Aug 2026
